Navigation Links
Medical experts: US unlikely to have enough vaccines to stop avian flu

A group of medical experts who attended a national avian flu conference last fall believe there is little chance the United States will be able to manufacture and stockpile enough vaccine or antiviral medication to stop a bird flu pandemic should the virus mutate into a form that can be spread easily from human to human, according to a survey led by researchers at Carnegie Mellon University. The results of the survey will be published in the June 2006 issue of the journal Global Public Health.

The 19 medical experts who attended the Pandefense 1.0 meeting in November gave a median estimate of a less than 1 percent chance that the U.S. will have adequate stockpiles of vaccines or antiviral drugs to prevent a pandemic within the next three years. The same experts gave a median estimate of 15 percent for the probability that the avian flu virus will mutate into a strain that can spread efficiently by human-to-human contact within that time. Their median worst-case estimate of the number of people who would die, should that happen, was 6 million in the United States and 180 million worldwide. Their median best-case estimates were 500,000 dead in the United States and 20 million worldwide.

"It surprised me that they thought it was going to be this bad," said Wändi Bruine De Bruin, lead author of the study and research faculty member in the Department of Social and Decision Sciences at Carnegie Mellon.

The survey also included 17 non-medical experts from a variety of fields who were more pessimistic about the likelihood of human-to-human transmission, giving a median 60 percent chance that it would occur within three years. They did, however, have more faith in medical science, giving a median 15 percent chance of the United States having enough vaccine and a 30 percent chance that the nation would have enough antiviral medications to halt a pandemic.

"The medical experts' estimates suggest this is a bigger risk than anything else we are fa
'"/>

Source:Carnegie Mellon University


Page: 1 2

Related biology news :

1. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Medical whistleblowers speak out
4. Access to antiretrovirals unlikely to reduce HIV infection rates
5. Ozone recovering, but unlikely to stabilize at pre-1980 levels, says study
6. Gene therapy to lower blood pressure just enough
7. A little telomerase isnt enough
8. Heart has enough oxygen to survive hypothermia, CPR crucial
9. Walking not enough for significant exercise benefits
10. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
11. Increase in drug development for killer diseases is not enough
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Medical experts unlikely have enough vaccines stop avian flu

(Date:8/19/2014)... fish purchased at retail seafood counters in 10 ... can expose consumers to unexpectedly high levels of ... falsely present a fish of the same species, ... dangerous mislabeling offense, according to new research by ... labeling of seafood is essential to allow consumers ...
(Date:8/19/2014)... University scientists have identified a biomarker strongly associated ... that is resistant to many types of chemotherapy. ... smart target for new therapeutics designed to treat ... patient data taken from The Cancer Genome Atlas, ... Tell used powerful computational and bioinformatics techniques to ...
(Date:8/19/2014)... -- ( Aug. 19, 2014 ) -- Scientists at ... to pick up and transfer single cells using a ... slightly. They describe this engineering feat and preliminary test ... of the American Chemical Society . , "Studying single ... in current biomedical research," said nanomedicine department. faculty member ...
Breaking Biology News(10 mins):Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3Moving single cells around -- accurately and cheaply 2
... together how the hominid Australopithecus sediba ( Au. ... ago. Their research, which appears in six papers in the ... that Au. sediba had a notable feature that ... flexible lower back. Together, the studies offer a comprehensive ...
... Boston University School of Medicine (BUSM) have pinpointed a ... airway cells harvested utilizing a minimally invasive procedure. The ... could lead to new treatments and ways to monitor ... online in the American Journal of Respiratory and ...
... On April 11 th JoVE ( Journal ... by Dr. Aydogan Ozcan demonstrating how a cell phone camera can ... make it possible for areas with limited resources to easily run ... patients. , In the new video article electrical and ...
Cached Biology News:New research reveals how human ancestor walked, chewed, and moved 2New research reveals how human ancestor walked, chewed, and moved 3BUSM researchers identify novel approach to study COPD and treatment efficacy 2BUSM researchers identify novel approach to study COPD and treatment efficacy 3Cell phone camera photographs microscopic cell samples 2
(Date:8/19/2014)... Shimadzu Scientific Instruments has introduced ... Nexera-i, adding to the company’s extensive line-up of ... intuitive operating environment, and full automation, the i-Series ... for conventional to ultra-high-speed analysis. , ... design so users can begin building the lab ...
(Date:8/19/2014)... , Aug. 19, 2014 Research and ... Fuel Cells (SOFCs) - Global Strategic Business Report" report ... worldwide markets for Solid Oxide Fuel Cells (SOFCs) in US$ ... Canada , Europe , ... estimates and forecasts are provided for the period 2012 through ...
(Date:8/19/2014)... Md. , Aug. 19, 2014 CSSi, ... research industry, recently announced the formation of the company,s ... to announce the addition of Dr. William E. ... - http://photos.prnewswire.com/prnh/20140818/136957 The MCAB, ... a variety of therapeutic areas and set strategic goals ...
(Date:8/19/2014)... 2014 Sales Horizons, a leader in ... online sales skills training course to help companies ... clinical staff spend the majority of their time on ... center, or physician practice – providing support and education ... there? Sales Horizons believes clinical staff are and should ...
Breaking Biology Technology:Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3
... , WILMINGTON, ... AZN ) and the University of Virginia ... into a strategic research collaboration to enhance development of ... a secondary focus on peripheral vascular disease (PAD). , ...
... Dec. 15 The Mosaic Company (NYSE: MOS ) plans ... financial tables on Tuesday, January 5, 2010, after the close of ... available on Mosaic,s website at mosaicco.com/investors. , The Company ... 6, 2010, to discuss the results. The call will begin ...
... , PHILADELPHIA, Dec. 15 The ... is pleased to announce the full agenda for the ... will take place at the Loews Philadelphia, on March 16-17, ... professionals have attended this premier event since its inception, and ...
Cached Biology Technology:AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2
...
... contains the basic components required for the ... and recombinant rat Thymus Chemokine-1 in cell ... sufficient materials to run ELISAs on approximately ... conditions are met: The assay ...
Blimp-1 (H-150)...
Mouse Galectin-1 Affinity Purified Polyclonal Ab...
Biology Products: